The objective of this contract is to support a variety of projects aimed at identifying and characterizing the correlates or markers of the immune status to infection with HTLV-III/LAV and to the subsequent progression of the infection to AIDS. The observation that some members of risk groups do not become infected (seroconvert) following a very high probability of exposure to the virus, and the finding that most individuals infected with the virus have not progressed to symptomatic disease let alone AIDS lends support to the view that protective immune mechanisms exist. A definitive understanding of the immune mechanisms that either prevent an initial infection or the progression of an infection to the fully developed disease would help provide a firmer scientific basis for vaccine development activities.
| Kelker, H C; Schlesinger, D; Valentine, F T (1994) Immunogenic and antigenic properties of an HIV-1 gp120-derived multiple chain peptide. J Immunol 152:4139-48 |
| Kelker, H C; Seidlin, M; Vogler, M et al. (1992) Lymphocytes from some long-term seronegative heterosexual partners of HIV-infected individuals proliferate in response to HIV antigens. AIDS Res Hum Retroviruses 8:1355-9 |
| Valentine, F T; Jacobson, M A (1990) Immunological and virological surrogate markers in the evaluation of therapies for HIV infection. AIDS 4 Suppl 1:S201-6 |
| Seidlin, M; Krasinski, K; Bebenroth, D et al. (1988) Prevalence of HIV infection in New York call girls. J Acquir Immune Defic Syndr 1:150-4 |
| Pinter, A; Honnen, W J (1988) A sensitive radioimmunoprecipitation assay for human immunodeficiency virus (HIV). J Immunol Methods 112:235-41 |
